nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexbrompheniramine—HRH1—Histamine receptors—HRH3—narcolepsy	0.27	0.27	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HRH3—narcolepsy	0.042	0.042	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—HTR2A—narcolepsy	0.0249	0.0249	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0229	0.0229	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0229	0.0229	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0221	0.0221	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0221	0.0221	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0209	0.0209	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0204	0.0204	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0204	0.0204	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0197	0.0197	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HCRT—narcolepsy	0.0188	0.0188	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0177	0.0177	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0177	0.0177	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0171	0.0171	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0168	0.0168	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—TRH—narcolepsy	0.0142	0.0142	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0127	0.0127	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0124	0.0124	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00964	0.00964	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.00946	0.00946	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00942	0.00942	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00924	0.00924	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00924	0.00924	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—PENK—narcolepsy	0.00844	0.00844	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00826	0.00826	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—TRH—narcolepsy	0.00717	0.00717	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00684	0.00684	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00684	0.00684	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00651	0.00651	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00651	0.00651	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.00629	0.00629	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.00629	0.00629	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.00591	0.00591	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.00591	0.00591	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00572	0.00572	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.00571	0.00571	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.00535	0.00535	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.00521	0.00521	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—NPS—narcolepsy	0.00521	0.00521	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.00486	0.00486	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00481	0.00481	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.00477	0.00477	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PENK—narcolepsy	0.00433	0.00433	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TRH—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	0.00355	0.00355	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	0.00349	0.00349	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	0.00349	0.00349	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—P2RY11—narcolepsy	0.00337	0.00337	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HRH3—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—NPS—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HCRT—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—NPS—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TAC1—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PENK—narcolepsy	0.00256	0.00256	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TRH—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HRH3—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TAC1—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NPS—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR2A—narcolepsy	0.000951	0.000951	CbGpPWpGaD
